| 
			  
			  
			
			
  
			Associated PressMay 20, 2010
 from 
			FoxNews Website
 
			  
			  
			
			
			 Craig Venter 
			Institute
 A scanning electron micrograph image of
 
			the synthetic 
			bacteria of M. mycoides JCVI-syn1.
 
			WASHINGTON 
			Scientists announced a bold step 
			Thursday in the enduring quest to create artificial life. They've 
			produced a living cell powered by manmade DNA. 
			While such work can evoke images of Frankenstein-like scientific 
			tinkering, it also is exciting hopes that it could eventually lead 
			to new fuels, better ways to clean polluted water, faster vaccine 
			production and more.
 
 Is it really an artificial life form?
 
 The inventors call it the world's first synthetic cell, although 
			this initial step is more a re-creation of existing life - changing 
			one simple type of bacterium into another - than a 
			built-from-scratch kind.
 
 But Maryland genome-mapping pioneer 
			
			J. Craig Venter said his 
			team's project paves the way for the ultimate, much harder goal: 
			designing organisms that work differently from the way nature 
			intended for a wide range of uses.
 
			  
			Already he's working with ExxonMobil in 
			hopes of turning algae into fuel. 
				
				"This is the first self-replicating 
				species we've had on the planet whose parent is a computer," 
				Venter told reporters. 
			And the report, being published Friday 
			in the journal Science, is triggering excitement in this growing 
			field of synthetic biology. 
				
				"It's been a long time coming, and 
				it was worth the wait," said Dr. George Church, a Harvard 
				Medical School genetics professor. "It's a milestone that has 
				potential practical applications." 
			Scientists for years have moved single 
			genes and even large chunks of DNA from one species to another. At 
			his 
			
			J. Craig Venter Institute in Rockville, Md., and San Diego, 
			Venter's team aimed to go further.  
			  
			A few years ago, the researchers 
			transplanted an entire natural genome - the genetic code - of one 
			bacterium into another and watched it take over, turning a goat germ 
			into a cattle germ. 
			  
			
			 
			Scientists have 
			developed the first cell (shown here)  
			controlled by a 
			synthetic genome - a revolution some are calling artificial life. 
			Next, the researchers built from scratch another, smaller 
			bacterium's genome, using off-the-shelf laboratory-made DNA 
			fragments.
 
 Friday's report combines those two achievements to test a big 
			question:
 
				
				Could synthetic DNA really take over and drive a living 
			cell?  
			Somehow, it did. 
				
				"This is transforming life totally 
				from one species into another by changing the software," said 
				Venter, using a computer analogy to explain the DNA's role. 
			The researchers picked two species of a 
			simple germ named 
			
			Mycoplasma.  
			  
			First, they chemically synthesized the 
			genome of M. mycoides, that goat germ, which with 1.1 million 
			"letters" of DNA was twice as large as the germ genome they'd 
			previously built.
 Then they transplanted it into a living cell from a different 
			Mycoplasma species, albeit a fairly close cousin.
 
 At first, nothing happened. The team scrambled to find out why, 
			creating a genetic version of a computer proofreading program to 
			spell-check the DNA fragments they'd pieced together.
 
			  
			They found that a typo in the genetic 
			code was rendering the manmade DNA inactive, delaying the project 
			three months to find and restore that bit. 
				
				"It shows you how accurate it has to 
				be, one letter out of a million," Venter said. 
			That fixed, the transplant worked.
			 
			  
			The recipient cell started out with 
			synthetic DNA and its original cytoplasm, but the new genome "booted 
			up" that cell to start producing only proteins that normally would 
			be found in the copied goat germ.  
			  
			The researchers had tagged the synthetic 
			DNA to be able to tell it apart, and checked as the modified cell 
			reproduced to confirm that new cells really looked and behaved like 
			M. mycoides. 
				
				"All elements in the cells after 
				some amount of time can be traced to this initial artificial 
				DNA. That's a great accomplishment," said biological engineer 
				Ron Weiss of the Massachusetts Institute of Technology. 
			Even while praising the accomplishment - 
			"biomolecular engineering of the highest order," declared 
			David Deamer of the University of California, Santa Cruz - many 
			specialists say the work hasn't yet crossed the line of truly 
			creating new life from scratch.
 It's partially synthetic, some said, because Venter's team had to 
			stick the manmade genetic code inside a living cell from a related 
			species. That cell was more than just a container; it also contained 
			its own cytoplasm - the liquid part.
 
 In other words, the synthetic part was "running on the 'hardware' of 
			the modern cell," University of Southern Denmark physics professor 
			Steen Rasmussen wrote in the journal Nature, which on Thursday 
			released essays of both praise and caution from eight leaders in the 
			field.
 
 The environmental group 
			
			Friends of the Earth said the new work took 
			"genetic engineering to an extreme new level" and urged that Venter 
			stop until government regulations are put in place to protect 
			against these kind of engineered microbes escaping into the 
			environment.
 
 Venter said he removed 14 genes thought to make the germ dangerous 
			to goats before doing the work, and had briefed government officials 
			about the work over the course of several years - acknowledging that 
			someone potentially could use this emerging field for harm instead 
			of good.
 
 But MIT's Weiss said it would be far easier to use existing 
			technologies to make 
			
			bio-weapons:
 
				
				"There's a big gap between science 
				fiction and what your imagination can do and the reality in 
				research labs." 
			Venter founded 
			
			Synthetic Genomics Inc., 
			a privately held company that funded the work, and his research 
			institute has filed patents on it. 
			    |